Aveo says FDA refuses to approve cancer drug

Aveo Oncology said June 10 that the Food and Drug Administration has refused to approve its cancer drug tivozanib, saying the clinical trial data supporting the drug was not clear.

http://www.fosters.com/apps/pbcs.dll/article?AID=/20130616/GJLIFESTYLES/130619691/-1/CITNEWS